AIM movers: Allergy Therapeutics accounts delayed and ex-dividends

Allergy Therapeutics (LON: AGY) says that its accounts will not be published by the end of 2022, so trading in the shares will be suspended on 3 January. The audit has been delayed, but there is no indication of any material problem. Management is still assessing funding options. The share price slumped 56% to 5p.

Annual results for Kazera Global (LON: KZG) will not be published until February, so trading in the shares will also be suspended on 3 January. Revenues were £107,000 and the loss was £1.125m. There was cash of £637,000 at the end of June 2022. The current cash position is £600,000. The share price dived by 19.1% to 0.85p.

- Advertisement -

Pathfinder Minerals (LON: PFP) has extended and increased a loan facility from £120,000 to £160,000. The facility lasts until the end of March 2023. The share price slipped by 9.52% to 0.475p.  

Myanmar Investments (LON: MIL) had a NAV of 28 cents a share at the end of September 2022. Concerns remain about the stability of Myanmar. The share price fell 6.25% to 7.5 cents a share.

Shares in Applied Graphene Materials (LON: AGM) have recovered a further 34.3% to 7.25p on the back of yesterday’s announcement that the company has received indicative proposals from interested parties for the sale of the business as part of the strategic review. Management hopes that there will be final proposals in early January, but there is no guarantee of a satisfactory deal.

NetScientific (LON: NSCI) investee company PDS Biotech (NASDAQ: PDSB) announced median overall survival of 21 months in a phase II study for a PDS0101-based triple combination therapy for advanced HPV+ cancer patients. This is better than current treatments. The PDS stake is worth more than £15m. The share price rose 14.9% to 77p, which values the investment and consultancy company at £18.1m.

- Advertisement -

Biotech company Sareum (LON: SAR) non-exec Dr Stephen Parker has bought 19,972 shares at 77.6p a share. The share price rose 10.7% to 77.5p.

There has been further director buying of genomic medicine company Yourgene Health (LON: YGEN) shares. Finance director Barry Hextall bought 3.4 million shares at 0.344p each. Chief operating officer Haydyn Jeffreys acquired 3.14 million shares at 0.366p each. The recent placing price was 0.3p a share. The share price is 6.67% higher at 0.4p.

Tekcapital (LON: TEK) investee company Innovative Eyewear has signed a global licensing agreement for the outdoor brand Eddie Bauer for smart eyewear.  The share price improved by 5.56% to 19p.

Ex-dividends

AB Dynamics (LON ABDP) is paying a final dividend of 3.54p a share and the share price fell 20p to 1590p.

Cerillion (LON: CER) is paying a final dividend of 6.5p a share and the share price is unchanged at 1200p.

Jet2 (LON: JET2) is paying an interim dividend of 3p a share and the share price declined by 20.4p to 965.6p.

James Latham (LON: LTHM) is paying an interim dividend of 7.25p a share and the share price is unchanged at 1250p.

Oxford Metrics (LON: OMG) is paying a final dividend of 2.5p a share and the share price slipped by 3p to 107.5p.

Real Estate Investors (LON: RLE) is paying a dividend of 0.44p a share and the share price is down by 0.75p to 28.75p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This

Tagdiv Cloud library - template content.